Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2
2004 · Biochemical Pharmacology · 177 citations
https://doi.org/10.1016/j.bcp.2004.11.002
A
Ans Punt
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
116
Papers
2.7K
Citations
33
h-index
62
i10-index
Ans Punt is an academic researcher from Unilever (United Kingdom). The author has contributed to research in topics: Carcinogens and Genotoxicity Assessment & Effects and risks of endocrine disrupting chemicals & Pharmacogenetics and Drug Metabolism. The author has an h-index of 33, co-authored 99 publications.
ORCID: 0000-0002-2056-4634Papers by this author
worksNext generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making
2018 · Computational Toxicology · 134 citations
https://doi.org/10.1016/j.comtox.2018.11.002
Impact of nanoparticle surface functionalization on the protein corona and cellular adhesion, uptake and transport
2018 · Journal of Nanobiotechnology · 107 citations
https://doi.org/10.1186/s12951-018-0394-6
Perfluoroalkyl substances (PFASs) are substrates of the renal human organic anion transporter 4 (OAT4)
2022 · Archives of Toxicology · 54 citations
https://doi.org/10.1007/s00204-022-03428-6
Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment
2022 · Archives of Toxicology · 37 citations
https://doi.org/10.1007/s00204-022-03356-5
Quantitative in vitro-to-in vivo extrapolation (QIVIVE) of estrogenic and anti-androgenic potencies of BPA and BADGE analogues
2019 · Archives of Toxicology · 34 citations
https://doi.org/10.1007/s00204-019-02479-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat